Now Europe’s Most Valuable Company, Can Novo Nordisk Live Up To Investor Expectations?
Appetite For Weight Loss Drug Remains Insatiable
Novo Nordisk has just become Europe’s most valuable company based on Wegovy’s huge success so far and future potential - but just how big could the obesity market get?
